Loss of DBC1 results in deregulation of MACC1 target gene expression, and DBC1 is required for cell proliferation, EMT properties, CSC-like traits, and drug resistance potential of colon cancer cells. This evidence concerns the gene MACC1 and malignant colon neoplasm.